Kissei Pharmaceutical Co., Ltd. Stock price

Equities

4547

JP3240600001

Pharmaceuticals

Delayed Japan Exchange 02:00:00 2024-03-28 am EDT 5-day change 1st Jan Change
3,535 JPY -0.70% Intraday chart for Kissei Pharmaceutical Co., Ltd. 0.00% +14.40%
Sales 2024 * 77.27B 510M Sales 2025 * 81.09B 535M Capitalization 156B 1.03B
Net income 2024 * 11.43B 75.48M Net income 2025 * 11.03B 72.84M EV / Sales 2024 * 2.02 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.93 x
P/E ratio 2024 *
14.5 x
P/E ratio 2025 *
14.2 x
Employees 1,359
Yield 2024 *
2.32%
Yield 2025 *
2.38%
Free-Float 65.43%
More Fundamentals * Assessed data
Dynamic Chart
Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program MT
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. CI
Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 8, 2023, has closed with 1,909,900 shares, representing 4.18% for ¥5,999.99 million. CI
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 2024 CI
Kissei Pharmaceutical Repurchases 251 Million Yen Worth of Shares in December 2023 MT
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. CI
Kissei and Maruishi Debut Injection for Dialysis-Related Itching MT
Kissei Pharmaceutical Co., Ltd. and Maruishi Pharmaceutical Co., Ltd. Announces KORSUVA®? IV Injection Syringe for Dialysis 17.5ug, 25.0ug to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis CI
Japanese Shares Close Lower on Tuesday After Key Economic Data MT
Kissei Pharmaceutical's Fiscal H1 Attributable Profit Surges as Net Sales Gains MT
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Kissei Pharmaceutical Co., Ltd. Announces Second Quarter-End Dividend for the Year Ending March 31, 2024, Payable on December 4, 2023 and Provided Dividend Guidance for the Year Ending March 31, 2024 CI
Jefferies Downgrades Kissei Pharmaceutical to Hold From Buy, Adjusts Price Target to 3,400 Yen From 3,300 Yen MT
Kissei Pharmaceutical Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ending September 30, 2023 CI
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. CI
More news
1 day-0.70%
Current month+4.12%
1 month+4.59%
3 months+12.22%
6 months+2.46%
Current year+14.40%
More quotes
1 week
3 475.00
Extreme 3475
3 625.00
1 month
3 365.00
Extreme 3365
3 720.00
Current year
3 060.00
Extreme 3060
3 720.00
1 year
2 598.00
Extreme 2598
3 720.00
3 years
2 026.00
Extreme 2026
3 720.00
5 years
2 002.00
Extreme 2002
3 720.00
10 years
1 915.00
Extreme 1915
3 975.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 76-03-31
Director of Finance/CFO 62 86-03-31
President 63 84-03-31
Members of the board TitleAgeSince
Chief Executive Officer 74 76-03-31
Director/Board Member 72 75-03-31
Director/Board Member 68 80-03-31
More insiders
Date Price Change Volume
24-03-28 3,535 -0.70% 80,200
24-03-27 3,560 +0.99% 127,500
24-03-26 3,525 +0.43% 87,400
24-03-25 3,510 -1.82% 110,600
24-03-22 3,575 +1.56% 87,800

Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT

More quotes
KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3,535 JPY
Average target price
3,833 JPY
Spread / Average Target
+8.44%
Consensus
  1. Stock
  2. Equities
  3. Stock Kissei Pharmaceutical Co., Ltd. - Japan Exchange